New and recently funded Medical Startups
1
Country: Spain
Healthy Buddy is an all-in-one healthy living app. It logs meals through AI photo recognition, barcode scanning or voice, runs an intermittent fasting timer, tracks workouts, supplements and mood, and plans weekly meals. Built by OndaDev, launched in February 2026, now used by more than 25,000 people across 10 languages on iOS and Android.
Healthy Buddy is an all-in-one healthy living app. It logs meals through AI photo recognition, barcode scanning or voice, runs an intermittent fasting timer, tracks workouts, supplements and mood, and plans weekly meals. Built by OndaDev, launched in February 2026, now used by more than 25,000 people across 10 languages on iOS and Android.
2
Country: USA | Funding: $103M
Hopscotch Primary Care is a healthcare company that aims to transform healthcare for rural communities across the country. It Hopscotch serves patients across the Southeastern U.S., but primarily in rural Western North Carolina.
Hopscotch Primary Care is a healthcare company that aims to transform healthcare for rural communities across the country. It Hopscotch serves patients across the Southeastern U.S., but primarily in rural Western North Carolina.
3
Country: USA | Funding: $213M
Epicrispr intends to treat rare muscle degeneration disease FSHD, which currently lacks approved therapies. It focuses on using epigenetic modification to modulate protein expression without directly editing DNA. Its drug candidate has already showed increases in lean muscle mass in patients during clinical trials.
Epicrispr intends to treat rare muscle degeneration disease FSHD, which currently lacks approved therapies. It focuses on using epigenetic modification to modulate protein expression without directly editing DNA. Its drug candidate has already showed increases in lean muscle mass in patients during clinical trials.
4
Country: USA
SpaceMD is a biotechnology company that focuses on microgravity environment to create pharmaceutical products.
SpaceMD is a biotechnology company that focuses on microgravity environment to create pharmaceutical products.
5
Country: Switzerland | Funding: $43.5M
Transmutex develops designs and software for an accelerator-powered technology that turns existing nuclear waste into clean energy and produces radioisotopes for medical and industrial applications. The startup is set to revolutionize the field of cancer diagnosis and treatment through the advanced production and development of radioactive isotopes. By extracting these elements from nuclear waste or directly producing them with its proton accelerator, the company intends to transform the landscape of medical diagnostics.
Transmutex develops designs and software for an accelerator-powered technology that turns existing nuclear waste into clean energy and produces radioisotopes for medical and industrial applications. The startup is set to revolutionize the field of cancer diagnosis and treatment through the advanced production and development of radioactive isotopes. By extracting these elements from nuclear waste or directly producing them with its proton accelerator, the company intends to transform the landscape of medical diagnostics.
6
Country: USA | Funding: $87M
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology. The startup is backed by Regeneron that is financing the development of a potential competitor to its inflammation blockbuster Dupixent for treating eczema, asthma, and COPD.
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology. The startup is backed by Regeneron that is financing the development of a potential competitor to its inflammation blockbuster Dupixent for treating eczema, asthma, and COPD.
7
Country: Egypt
digital healthcare platform that helps patients discover trusted doctors, book appointments, and manage their medical journey in one place. Its goal is to simplify healthcare access and make medical services more accessible across Egypt and the region
digital healthcare platform that helps patients discover trusted doctors, book appointments, and manage their medical journey in one place. Its goal is to simplify healthcare access and make medical services more accessible across Egypt and the region
8
Country: USA | Funding: $276.8M
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
9
Country: USA | Funding: $31M
Rylo offers an FCC-certified platform for deaf and hard-of-hearing users that provides real-time captioning and text-to-speech capabilities for phone calls and in-person communication. It develops additional AI-powered tools for workplace accessibility, network improvements, speaker characteristics, sentiment analysis and real-time fraud detection.
Rylo offers an FCC-certified platform for deaf and hard-of-hearing users that provides real-time captioning and text-to-speech capabilities for phone calls and in-person communication. It develops additional AI-powered tools for workplace accessibility, network improvements, speaker characteristics, sentiment analysis and real-time fraud detection.
10
Country: USA | Funding: $22.6M
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
Fesarius Therapeutics is focused on dermal repair. Its lead product, DermiSphere hDRT, is FDA-cleared hydrogel dermal regeneration template designed for wound management. It's as a dual-density collagen hydrogel template that supports cellular invasion and vascularized tissue regeneration. The company said also develops OneStep procedure that DermiSphere and a split-thickness skin graft to be applied simultaneously and thus reduce recovery time, pain and total cost of care (in comparison with current two-stage approach for some full-thickness skin-loss cases, when a surgeon places a dermal substitute in one procedure, and then the patient returns for a second surgery after the template has vascularized enough to support a skin graft).
